| Literature DB >> 33939479 |
Tomás P Griffin1, Sean F Dinneen1.
Abstract
SOURCE CITATION: Wittert G, Bracken K, Robledo KP, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021;9:32-45. 33338415.Entities:
Year: 2021 PMID: 33939479 DOI: 10.7326/ACPJ202105180-054
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391